Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Oncotarget|April 21, 2017
The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-β- catenin signaling axisAraceli Valverde, Jon Peñarando, Amanda Cañas, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2011
Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot studyFrancisco C Muñoz-Casares, Sebastián Rufián, Álvaro Arjona-Sánchez, et al.
Plos One|June 17, 2014
CoCl2, a mimic of hypoxia, induces formation of polyploid giant cells with stem characteristics in colon cancerLaura M Lopez-Sánchez, Carla Jimenez, Araceli Valverde, et al.
Clinical Epigenetics|July 22, 2023
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancerMaría Victoria García-Ortiz, Pablo Cano-Ramírez, Marta Toledano-Fonseca, et al.
BMC Cancer|May 1, 2015
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI studyPilar Garcia-Alfonso, Manuel Chaves, Andrés Muñoz, et al.
Frontiers in Oncology|February 5, 2025
Prioritizing breast cancer surgeries: insights from the KRONOS SCORELucía Navarro, Luis Perez-Bartivas, David Ponferrada, et al.
European Journal of Clinical Investigation|October 29, 2015
Genetic variants in the renin-angiotensin system predict response to bevacizumab in cancer patientsDiana Moreno-Muñoz, Juan R de la Haba-Rodríguez, Francisco Conde, et al.
JCO Oncology Practice|February 23, 2021
Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and ImplicationsCarlos Camps, Rafael López, Antonio Antón, et al.
Acta Oncologica (Stockholm, Sweden)|October 25, 2007
Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II studyAlbert Abad, Bartomeu Massuti, Antonio Antón, et al.
Frontiers in Pharmacology|March 12, 2024
NeuroPredict: study of the predictive value of ABCB1 genetic polymorphisms and associated clinical factors in chronic chemotherapy-induced peripheral neuropathy (CIPN)Alicia Vargas-Aliaga, María De la Haba, María José Contreras, et al.
Pageof 15